Derivation and High Engraftment of Patient-Specific Cardiomyocyte Sheet Using Induced Pluripotent Stem Cells Generated From Adult Cardiac Fibroblast

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation: Heart Failure

• Publication date

  2015-01-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.114.001317PMID 25420485PMCID PMC4303534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Legionella Kinase LegK2 Targets the ARP2/3 Complex To Inhibit Actin Nucleation on Phagosomes and Allow Bacterial Evasion of the Late Endocytic Pathway

  2015cited by this paper
• Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells

  2013cited by this paper
• Effective Cardiac Myocyte Differentiation of Human Induced Pluripotent Stem Cells Requires VEGF

  2013cited by this paper
• An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells

  2013cited by this paper
• Functional Consequences of Human Induced Pluripotent Stem Cell Therapy: Myocardial ATP Turnover Rate in the In Vivo Swine Heart With Postinfarction Remodeling

  2013cited by this paper
• Definitive Endoderm Formation from Plucked Human Hair-Derived Induced Pluripotent Stem Cells and SK Channel Regulation

  2013cited by this paper
• Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny

  2012cited by this paper
• hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts

  2012cited by this paper
• Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells: The Matrix Sandwich Method

  2012cited by this paper
• Bioenergetic and Functional Consequences of Cellular Therapy: Activation of Endogenous Cardiovascular Progenitor Cells

  2012cited by this paper
• Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy

  2012cited by this paper
• Epidemiology and risk profile of heart failure

  2011cited by this paper
• Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells.

  2011cited by this paper
• Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells

  2011cited by this paper
• Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures

  2011cited by this paper
• Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation

  2010cited by this paper
• Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale

  2010cited by this paper
• Epigenetic memory in induced pluripotent stem cells

  2010cited by this paper
• Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells

  2009cited by this paper
• Engraftment, Differentiation, and Functional Benefits of Autologous Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopathy

  2009cited by this paper
• Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors

  2008cited by this paper
• Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function

  2008cited by this paper
• Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

  2008cited by this paper
• Xenotransplantation of Long‐Term‐Cultured Swine Bone Marrow‐Derived Mesenchymal Stem Cells

  2007cited by this paper
• FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction

  2006cited by this paper
• Current updates in perioperative management of intracerebral hemorrhage.

  2006cited by this paper
• Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts

  2006cited by this paper
• Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space.

  2004cited by this paper
• Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts.

  1999cited by this paper
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

  1983cited by this paper

• Engineering cardiology with miniature hearts

  2025cites this paper
• Biomaterial platforms in cardiovascular regenerative medicine - challenges and future perspectives.

  2025cites this paper
• Optical mapping of the interface between iPSC-derived grafts and swine myocardium suggests potential arrhythmia mechanisms

  2025cites this paper
• A fibrin gel-loaded Gouqi-derived nanovesicle (GqDNV) repairs the heart after myocardial infarction by inhibiting p38 MAPK/NF-κB p65 pathway

  2025cites this paper
• Optimizing extracellular matrix for endothelial differentiation using a design of experiments approach

  2025cites this paper
• Epitranscriptomic Modulation of TET2 Inhibition Suppressed SARS-CoV-2 Infection and Blocked Viral Nucleocapsid Protein in Induced-Pluripotent-Stem-Cell-Derived Cardiomyocyte Screening Models

  2025cites this paper
• DMSO-free cryopreservation of hiPSC-derived cardiomyocytes: low temperature characterization and protocol development

  2025cites this paper
• DMSO-free cryopreservation of hiPSC-derived cardiomyocytes: Low temperature characterization and protocol development

  2025cites this paper
• TSH upregulates CYP4B1 through the PI3K/AKT/CREB pathway to promote cardiac hypertrophy

  2025cites this paper
• To Repair a Broken Heart: Stem Cells in Ischemic Heart Disease

  2024cites this paper
• Follistatin From hiPSC-Cardiomyocytes Promotes Myocyte Proliferation in Pigs With Postinfarction LV Remodeling

  2024cites this paper
• Optogenetic stimulation and simultaneous optical mapping of membrane potential and calcium transients in human engineered cardiac spheroids.

  2024cites this paper
• Dynamic three dimensional environment for efficient and large scale generation of smooth muscle cells from hiPSCs

  2024cites this paper
• Induced pluripotent stem cell therapies in heart failure treatment: a meta-analysis and systematic review.

  2024cites this paper
• Myocardial Recovery versus Myocardial Regeneration: Mechanisms and Therapeutic Modulation

  2024cites this paper
• Healthy human induced pluripotent stem cell-derived cardiomyocytes exhibit sex dimorphism even without the addition of hormones

  2024cites this paper
• Induced Pluripotent Stem Cell-Derived Cardiomyocytes Therapy for Ischemic Heart Disease in Animal Model: A Meta-Analysis

  2024cites this paper
• Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts

  2023cites this paper
• Assessment of Fallopian Tube Epithelium Features Derived from Induced Pluripotent Stem Cells of Both Fallopian Tube and Skin Origins

  2023cites this paper
• Advances in the design, generation, and application of tissue-engineered myocardial equivalents

  2023cites this paper
• CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs

  2023cites this paper
• Progress and promise of cell sheet assisted cardiac tissue engineering in regenerative medicine

  2023cites this paper
• Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice

  2023cites this paper
• Engineering of thick human functional myocardium via static stretching and electrical stimulation

  2022cites this paper
• Layer-By-Layer Fabrication of Thicker and Larger Human Cardiac Muscle Patches for Cardiac Repair in Mice

  2022cites this paper
• A three-dimensional culture system for generating cardiac spheroids composed of cardiomyocytes, endothelial cells, smooth-muscle cells, and cardiac fibroblasts derived from human induced-pluripotent stem cells

  2022cites this paper
• The Progress of Stem Cell Therapy in Myocardial-Infarcted Heart Regeneration: Cell Sheet Technology

  2022cites this paper
• Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study

  2022cites this paper
• miR-199a Overexpression Enhances the Potency of Human Induced-Pluripotent Stem-Cell–Derived Cardiomyocytes for Myocardial Repair

  2021cites this paper
• Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction

  2021cites this paper
• Cardiac Fibroblasts and Myocardial Regeneration

  2021cites this paper
• Application of Human Induced Pluripotent Stem Cell Technology for Cardiovascular Regenerative Pharmacology.

  2021cites this paper
• Stem cell-based approaches in cardiac tissue engineering: controlling the microenvironment for autologous cells.

  2021cites this paper
• Application of Cell, Tissue, and Biomaterial Delivery in Cardiac Regenerative Therapy.

  2021cites this paper
• Role of prostaglandin E2 in allogeneic mesenchymal stem cell therapy for cardiac repair.

  2021cites this paper
• Efficient Protocols for Fabricating a Large Human Cardiac Muscle Patch from Human Induced Pluripotent Stem Cells.

  2021cites this paper
• Considerations for the Bioengineering of Advanced Cardiac In Vitro Models of Myocardial Infarction.

  2021cites this paper
• Recent progress in induced pluripotent stem cell-derived 3D cultures for cardiac regeneration

  2021cites this paper
• Cell Therapy And Methods Of Stem Cell Delivery For Regeneration Of Heart Tissue Following Myocardial Infarction

  2021cites this paper
• Chirurgische Beiträge zur kardialen Stammzelltherapie

  2021cites this paper
• Advanced Technologies to Target Cardiac Cell Fate Plasticity for Heart Regeneration

  2021cites this paper
• Bioreactor Suspension Culture: Differentiation and Production of Cardiomyocyte Spheroids From Human Induced Pluripotent Stem Cells

  2021cites this paper
• Stem Cell Therapy of Myocardial Infarction: A Promising Opportunity in Bioengineering

  2020cites this paper
• Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction

  2020cites this paper
• DNA Damage-Free iPS Cells Exhibit Potential to Yield Competent Cardiomyocytes.

  2020cites this paper
• 3D bioprinting and its potential impact on cardiac failure treatment: An industry perspective

  2020cites this paper
• New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence

  2020cites this paper
• Nano‐ and Microfabrication for Engineering Native‐Like Muscle Tissues

  2020cites this paper
• Cardiac progenitor cells, tissue homeostasis, and regeneration

  2020cites this paper
• Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine

  2020cites this paper
• Preseeding of Mesenchymal Stem Cells Increases Integration of an iPSC-Derived CM Sheet into a Cardiac Matrix.

  2020cites this paper
• Generation of transgene-free induced pluripotent stem cells from cardiac fibroblasts of goat embryos.

  2020cites this paper
• N-cadherin Overexpression Enhances the Reparative Potency of Human iPSC-Derived Cardiac Myocytes in Infarcted Mouse Hearts.

  2019cites this paper
• Cardiac Patch-Based Therapies of Ischemic Heart Injuries

  2019cites this paper
• Cardiovascular Regenerative Medicine

  2019influential citation
• Precisely Control Mitochondria with Light to Manipulate Cell Fate Decision.

  2019cites this paper
• Cardiac Tissue Engineering

  2019cites this paper
• HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury.

  2019cites this paper
• Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy.

  2019cites this paper
• Potential Applications of Induced Pluripotent Stem Cells for Cardiovascular Diseases.

  2019cites this paper
• Deciphering Role of Wnt Signalling in Cardiac Mesoderm and Cardiomyocyte Differentiation from Human iPSCs: Four-dimensional control of Wnt pathway for hiPSC-CMs differentiation

  2019cites this paper
• Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice

  2018cites this paper
• Can We Engineer a Human Cardiac Patch for Therapy?

  2018cites this paper
• The march of pluripotent stem cells in cardiovascular regenerative medicine

  2018cites this paper
• Transactivation domain of p53 regulates DNA repair and integrity in human iPS cells.

  2018cites this paper
• Relationship Between the Efficacy of Cardiac Cell Therapy and the Inhibition of Differentiation of Human iPSC-Derived Nonmyocyte Cardiac Cells Into Myofibroblast-Like Cells

  2018cites this paper
• Efficient generation of functional cardiomyocytes from human umbilical cord-derived virus-free induced pluripotent stem cells

  2018cites this paper
• Extracellular Vesicles Released by Human Induced-Pluripotent Stem Cell-Derived Cardiomyocytes Promote Angiogenesis

  2018cites this paper
• Keratose Hydrogels Promote Vascular Smooth Muscle Differentiation from c-kit+ Human Cardiac Stem Cells: Underlying Mechanism and Therapeutic Potential

  2018cites this paper
• CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Remuscularization of Injured Ventricle

  2018cites this paper
• Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.

  2018cites this paper
• A Multiwell Cardiac μGMEA Platform for Action Potential Recordings from Human iPSC-Derived Cardiomyocyte Constructs

  2018cites this paper
• Precisely control mitochondrial membrane potential with light to manipulate cell fate decisions

  2018cites this paper
• Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies

  2018cites this paper
• Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)

  2017cites this paper
• Effect of densely ionizing radiation on cardiomyocyte differentiation from human‐induced pluripotent stem cells

  2017cites this paper
• Differentiation and Use of Induced Pluripotent Stem Cells for Cardiovascular Therapy and Tissue Engineering

  2017cites this paper
• Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell–Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine

  2017cites this paper
• Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases.

  2017cites this paper
• Stem cells and heart disease - Brake or accelerator?

  2017cites this paper
• Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold

  2017influential citation
• Towards the standardization of stem cell therapy studies for ischemic heart diseases: Bridging the gap between animal models and the clinical setting.

  2017cites this paper
• Small-scale Propagation of Human iPSCs in Serum-free Conditions for Routine Immunocytochemical Characterization.

  2017cites this paper
• Lactate Promotes Synthetic Phenotype in Vascular Smooth Muscle Cells

  2017cites this paper
• Progress of Stem Cell Transplantation for Treating Myocardial Infarction.

  2017cites this paper
• Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform☆

  2016cites this paper
• Stem cells and exosomes in cardiac repair.

  2016cites this paper
• Cardiac Tissue Engineering: Using Induced Pluripotent Stem Cells to Repair Damaged Cardiac Tissue

  2016cites this paper
• Navigating the labyrinth of cardiac regeneration

  2016cites this paper
• Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction.

  2016cites this paper
• Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols

  2016cites this paper
• Gene Therapy and Stem Cells in the Treatment of Congenital Diseases

  2015cites this paper
• Cell Sheet‐Based Tissue Engineering for Organizing Anisotropic Tissue Constructs Produced Using Microfabricated Thermoresponsive Substrates

  2015cites this paper
• Functional Effects of a Tissue‐Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes in a Rat Infarct Model

  2015cites this paper
• Stimulating endogenous cardiac repair

  2015influential citation
• Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart Failure

  2015cites this paper
• Resveratrol Enhances Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells through Inhibiting Canonical WNT Signal Pathway and Enhancing Serum Response Factor-miR-1 Axis

  2015cites this paper
• Journal of Stem Cell Research

  year unknowncites this paper